The pharmaceutical industry is aggressively evolving, with increasing demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To fulfill this demand, US-based manufacturing services are gaining traction. These organizations offer a wide-ranging suite of services, from